Pharmacy Benefit Management: The Cost of Drug Price Rebates

Journal of Law, Medicine and Ethics 51 (S2):52-54 (2023)
  Copy   BIBTEX

Abstract

Pharmacy Benefit Managers (PBM) induce drug manufacturers to offer rebates to insurers and employers by denying coverage through formulary exclusions, impeding physician prescription through prior authorization, and reducing patient drug use through cost sharing. As they tighten these access obstacles, PBMs reduce the net prices received by the manufacturers.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,072

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Addressing High Drug Prices by Reforming Pharmacy Benefit Managers.Benjamin N. Rome - 2023 - Journal of Law, Medicine and Ethics 51 (S2):46-51.
Aiming at the Right Targets on Drug Price Reform.Stacie B. Dusetzina - 2023 - Journal of Law, Medicine and Ethics 51 (S2):55-57.
Why High Drug Pricing Is A Problem for Research Ethics.Spencer Phillips Hey - 2020 - Journal of Bioethical Inquiry 17 (1):29-35.
Recent Case Developments in Health Law.Stacy Clark, Jessica Palmer & Dayna Fullerton - 2010 - Journal of Law, Medicine and Ethics 38 (1):160-167.

Analytics

Added to PP
2024-03-05

Downloads
10 (#1,470,828)

6 months
3 (#1,471,455)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references